Staging strategies for pancreatic adenocarcinoma: What the surgeon really wants to know

Current Gastroenterology Reports

Volumn 5, Issue 2, 2003, Pages 117-124

  Sarmiento, Juan M ^b   Sarr, Michael G ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ASPIRATION BIOPSY; CANCER ADJUVANT THERAPY; CANCER PALLIATIVE THERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPY; HUMAN; LAPAROSCOPY; LYMPH NODE METASTASIS; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MEDICAL DECISION MAKING; METASTASIS POTENTIAL; METHODOLOGY; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; PANCREAS SURGERY; PATIENT SELECTION; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; PHYSICIAN ATTITUDE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; SURGEON; TREATMENT OUTCOME; VATER PAPILLA CARCINOMA; ADENOCARCINOMA; ALGORITHM; COMPUTER ASSISTED EMISSION TOMOGRAPHY; PANCREAS TUMOR; PATHOLOGY;

ADENOCARCINOMA; ALGORITHMS; ENDOSONOGRAPHY; HUMANS; LAPAROSCOPY; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; PANCREATIC NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0038644660     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-003-0080-0     Document Type: Review

References (42)

1. Kalser MH, Barkin J, MacIntyre JM: Pancreatic cancer: assessment of prognosis by clinical presentation. Cancer 1985, 56:397-402.
2. Fortner JG: 'Radical' abdominal cancer surgery: current state and future course. Japan J Surg 1989, 19:503-509.
3. Bold RJ, Charnsangavej C, Cleary KR, et al.: Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis. J Gastrointest Surg 1999, 3:233-243.
4. Harrison LE, Brennan MF: Portal vein resection for pancreatic adenocarcinoma. Surg Oncol Clin North Am 1998, 7:165-181.
5. Fuhrman GM, Leach SD, Staley CA, et al.: Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Ann Surg 1996, 223:154-162.
6. Rosewicz S, Wiedenmann B: Pancreatic carcinoma. Lancet 1997, 349:485-489.
7. Horton KM: Multidetector CT and three-dimensional imaging of the pancreas: state of the art. J Gastrointest Surg 2001, 6:126-128.
8. Tamm E, Charnsangavej C: Pancreatic cancer: current concepts in imaging for diagnosis and staging. Cancer J 2001, 7:298-311.
9. Zeman RK, Cooper C, Zeiberg AS, et al.: TNM staging of pancreatic carcinoma using helical CT. AJR Am J Roentgenol 1997, 169:459-464.
10. Jimenez RE, Warshaw AL, Rattner DW, et al.: Impact of laparoscopic staging in the treatment of pancreatic cancer. Arch Surg 2000, 135:409-415.
11. Conlon KC, Dougherty E, Klimstra DS, et al.: The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann Surg 1996, 223:134-140.
12. Rumstadt B, Schwab M, Schuster K, et al.: The role of laparoscopy in the preoperative staging of pancreatic carcinoma. J Gastrointest Surg 1997, 1:245-250.
13. Friess H, Kleef J, Silva JC, et al.: The role of diagnostic laparoscopy in pancreatic and periampullary malignancies. J Am Coll Surg 1998, 186:675-682.
14. Spitz FR, Abbruzzese JL, Lee JE, et al.: Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 1997, 15:928-937.
15. Habr F, Akerman P: Role of endoscopic ultrasound in the diagnosis and staging of pancreatic cancer. Front Biosci 2000, 5:30-35.
16. Baron PL, Aabakken LE, Cole DJ, et al.: Differentiation of benign from malignant pancreatic masses by endoscopic ultrasound. Ann Surg Oncol 1997, 4:639-643.
17. Mertz HR, Sechopoulos D, Delbeke D, Leach SD: EUS, PET and CT scanning for evaluation of pancreatic adenocarcinoma. Gastrointest Endosc 2000, 52:367-371.
18. Palazzo L, Roseau G, Gayet B, et al.: Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma: results of a prospective study with comparison to ultrasonography and CT scan. Endoscopy 1993, 25:143-150.
19. Gress F, Gottlieb K, Sherman S, Lehman G: Endoscopic ultrasonography-guided fine-needle aspiration biopsy of suspected pancreatic cancer. Ann Intern Med 2001, 134:459-464.
20. Legmann P, Vignaux O, Dousset B, et al.: Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol 1998, 170:1315-1322.
21. Brugge WR, Lee MJ, Kelsey PB, et al.: The use of EUS to diagnose malignant portal venous invasion by pancreatic cancer. Gastrointest Endosc 1996, 43:561-567.
22. Ichikawa T, Haradome H, Hachiya J, et al.: Pancreatic ductal adenocarcinoma: preoperative assessment with helical CT versus dynamic MR imaging. Radiology 1997, 202:655-662.
23. Sheridan MB, Ward J, Guthrie JA, et al.: Dynamic contrast-enhanced MR imaging and dual-phase helical CT in the preoperative assessment of suspected pancreatic cancer: a comparative study with receiver operating characteristic analysis. AJR Am J Roentgenol 1999, 173:583-590.
24. Nishiharu T, Yamashita Y, Abe Y, et al.: Local extension of pancreatic carcinoma: assessment with thin-section helical CT versus with breath-hold fast MR imaging-ROC analysis. Radiology 1999, 212:445-452.
25. Temudom T, Sarr MG, Douglas MG, Farnell MB: An argument against routine percutaneous biopsy, ERCP, or biliary stent placement in patients with clinically resectable periampullary masses: a surgical perspective. Pancreas 1995, 11:283-288.
26. Diederichs CG: Pancreatic cancer. In PET in Oncology. Edited by Ruhlmann J, Oehr P, Biersack HJ. Berlin: Springer-Verlag; 1999:128-134.
27. Rose DM, Delbeke D, Beauchamp RD, et al.: 18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer. Ann Surg 1999, 229:729-737.
28. Keogan MT, Tyler D, Clark L, et al.: Diagnosis of pancreatic carcinoma: role of FDG PET. AJR Am J Roentgenol 1998, 171:1565-1570.
29. Ho C, Dehdashti F, Griffeth LK, et al.: FDG-PET evaluation of indeterminate pancreatic masses. J Comput Assist Tomogr 2000, 20:363-369.
30. Bares R, Klever P, Hauptmann S, et al.: F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 1994, 192:79-86.
31. Diederichs CG, Staib L, Vogel J, et al.: Values and limitations of 18-F fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses. Pancreas 2000, 20:109-116.
32. Zimmy M, Bares R, Fass J, et al.: Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases. Eur J Nucl Med 1997, 24:678-682.
33. Pisters PWT, Lee JE, Vauthey IN, et al.: Laparosocpy in the staging of pancreatic cancer. Br J Surg 2001, 88:325-337.
34. Vollmer CM, Drebin JA, Middleton WD, et al.: Utility of staging laparoscopy in subsets of peripancreatic and biliary malignancies. Ann Surg 2002, 235:1-7.
35. Luque-de Leon E, Tsiotos GG, Balsiger B, et al.: Staging laparoscopy for pancreatic cancer should be used to select the best means of palliation and not only to maximize resectability rate. J Gastrointest Surg 1999, 3:111-118.
36. John TG, Greig JD, Carter DC, Garden OJ: Carcinoma of the pancreatic head and periampullary region: tumor staging with laparoscopy and laparoscopic ultrasonography. Ann Surg 1995, 221:156-164.
37. Shoup M, Brennan MF, O'Reilly E, et al.: Should patients with locally advanced pancreatic adenocarcinoma undergo laparoscopic staging prior to initiation of chemoradiation? Presented at Digestive Disease Week, San Francisco, CA. May 19-22, 2002.
38. Saldinger PF, Reilly M, Reynolds K, et al.: Is CT angiography sufficient for prediction of resectability of periampullary neoplasms? J Gastrointest Surg 2000, 4:233-237.
39. Todd KE, Gloor B, Lane JS, et al.: Resection of locally advanced pancreatic cancer after downstaging with continuous-infusion 5-fluorouracil, mitomycin-C, leucovorin, and dipyridamole. J Gastrointest Surg 1998, 2:159-166.
40. Bajetta E, Di Bartolomeo M, Stani SC, et al.: Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility study. Int J Radiat Oncol Biol Phys 1999, 45:285-289.
41. Snady H, Bruckner H, Cooperman A, et al.: Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma: an outcomes trial. Cancer 2000, 89:314-327.
42. Kim HJ, Czischke K, Brennan MF, Conlon KC: Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer? J Gastrointest Surg 2002, 6:763-769.